FDA Inspection 1031331 — Miranda Gogishvili
The FDA completed an inspection of Miranda Gogishvili on Oct 18, 2017 in Tbilisi. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 18, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Tbilisi (Georgia)
Additional Details
Clinical Investigator (CI)